Respiratory syncytial virus (RSV) is a major cause of respiratory illness in babies and young children every year from late fall to early spring. With the two newly approved RSV treatments, Beyfortus and Abrysvo, by the Food and Drug Administration (FDA) for babies and pregnant women, families will be able to get ahead of the […]